Recently visited unit
name Price (yuan) Rise and fall
The following are popular stocks
Please check the self selected shares first
@change@
@changeP@
@now@
Limit: @ up_limit@
Limit: @ down_limit@
Suspension
@date@ @time@
Temporary suspension
Today: @open@ Volume: @volume@ Amplitude: @swing@
Maximum: @high@ Turnover: @amount@ turnover rate: @turnover@
Minimum: @low@ Total Market Value: @fixTotalShare@ P/B ratio: @pb@
Received yesterday: @preClose@ Circulation value: @cvs@ P/E ratio TTM @pe@
Total share capital: @zgb@ Circulating shares: @ltgb@
Information mine:
    The browser version is too low to view the multi null inversion

    Your browser version is too low to view empty data. It is recommended to use IE10 (including) above Firefox Google

    Time-sharing
    Day K
    Week K
    Month K
    K line
    Reinstatement K line
    Technical drawings
    Also concerned:
      5th gear disc opening
      Live broadcast of famous teachers
      Commission ratio -- Abandonment --
      Selling ⑤ -- --
      Sell ④ -- --
      Selling ③ -- --
      Sell ② -- --
      Selling ① -- --
      deal --
      Buy ① -- --
      Buy ② -- --
      Buy ③ -- --
      Buy ④ -- --
      Buy ⑤ -- --
      Outer disc -- Inner disc --

      In case of a key big order, the main force may**

      Quickly use level2 to view details>
      time Price (yuan) Measurement (hand) nature
      time Price (yuan) Measurement (hand) nature
      Transaction price (yuan) Trading volume (hand) Proportion (%)
      time Transaction price (yuan) Trading volume (hand)
      Product entry: Sina Finance APP - Stocks - Investment Research Report
      Product entrance: Sina Finance APP - stock - free question
      Product entrance: Sina Finance APP - stock - free question
      Main and retail investors' capital flow
      Main buy Main sales Purchase by retail investors Retail sales
      Amount (10000 yuan) @mainIn@ @mainOut@ @retailIn@ @retailOut@
      proportion @mainInP@ @mainOutP@ @retailInP@ @retailOutP@
      Loose bill
      Small order
      Large order
      Extra large order
      Net inflow of classified funds
      Loose bill Small order Large order Extra large order
      Net inflow (10000 yuan) @r3_r_in@ @r2_r_in@ @r1_r_in@ @r0_r_in@
      Proportion in the flow board @r3_p_svs@ @r2_p_svs@ @r1_p_svs@ @r0_p_svs@
      Proportion in turnover rate @r3_p_turnover@ @r2_p_turnover@ @r1_p_turnover@ @r0_p_turnover@
      title click reply Final reply

      Company research

      Hot data

      more
      Adjacent ranking
      Top 10 in the industry

      Financial ratios

      more
      Adjacent ranking
      Top 10 in the industry

      Investment rating of research institutions

      more

      In the last 60 days Six research reports released Shutaishen (sz300204) rating, and the comprehensive rating is as follows:

      Hot columns

      Industry comparison

      name Price (yuan)

      corporate name:

      Shutaishen (Beijing) Biological Pharmaceutical Co., Ltd

      Main business:

      It is mainly engaged in the R&D, production and sales of biological products and some chemicals.

      Telephone: 010-67875255

      Fax: 010-67875255

      Date of establishment: 2002-08-16

      Listing date: 2011-04-15

      Legal representative: Zhou Zhiwen

      general manager: Wang Chao

      Registered capital: 477.773 million yuan

      Issue price: 52.500 yuan

      Latest total share capital: 477772555 shares

      Latest outstanding shares: 471640766 shares

      Segment: GEM Shenzhen A-share Shanghai and Shenzhen A-share Shenzhen Composite Index Manufacturing index Pharmaceutical index Equity incentive Pharmaceuticals Shenzhen Stock Connect Shenzhen Stock Connect Innovative medicine Pharmaceutical Biology

      2024-03
      2023-12
      2023-09
      2023-06
      2023-03
      Earnings per share -0.0079 yuan -0.8349 yuan -0.3872 yuan -0.3228 yuan -RMB 0.1025
      net asset value per share 2.1539 yuan 2.1363 yuan 2.4661 yuan 2.5725 yuan 2.6829 yuan
      Net operating cash flow per share -0.0356 yuan -0.4779 yuan -RMB 0.2964 -0.2337 yuan -RMB 0.1025
      Return on net assets -0.37% -39.08% -15.70% -12.55% -3.82%
      Undistributed profit per share -RMB 0.5378 -RMB 0.5296 -0.0815 yuan -0.0161 yuan RMB 2035
      Capital reserve per share 1.1187 yuan 1.1187 yuan 1.1187 yuan 1.0926 yuan 1.0926 yuan
      Date of announcement Allocation scheme
      2019-05-10 10 Pairs RMB 6.681
      2018-03-14 10 pies 2.5 yuan
      2017-04-24 10 pies 1.8 yuan
      2016-04-27 RMB 1.998 transferred from 10 shares to 3.996 shares
      2015-04-01 10 RMB 3 to 4 shares
      2024-03
      2023-12
      2023-09
      Name of shareholders Shareholding (%) Increase or decrease
      Yizhao (Beijing) Medical thirty-six point five eight one Unchanged
      Xiangtang Group Co., Ltd eight point seven nine three Unchanged
      Huatai Securities Asset Management - one point nine eight nine Unchanged
      Zhang Yong one point zero one two Overweight
      Zuo Conglin zero point nine one two Unchanged
      HKSCC has zero point nine one zero reduce one's shares in a listed company
      Hu Haiyan zero point four nine eight New progress
      Guo Fuxin zero point three seven five Overweight
      Huang Jiaoying zero point three zero nine New progress
      Zhou Zhiwen zero point two eight zero New progress

      Shareholding ratio of circulating shareholders



      user name:
      Password: